longbridge

Lycia Therapeutics

LYCA
31.4400.45% ( +0.140 )
Closed: Nov 11, 15:59:58 (EDT)

All Shareholders

Shareholder Type

  • Public and others48.11%
  • VC/PE firms22.94%
  • Hedge funds13.53%
  • Institutions10.55%
  • Others4.87%

Major Shareholders

Major Shareholders Latest
Shareholder
Versant Venture Management, LLC
12.18%7.03M--+7.03M
VR Management, LLC
10.76%6.21M--+6.21M
Redmile Group, LLC
7.22%4.16M--+4.16M
RTW Investments, LP
6.31%3.64M--+3.64M
Janus Henderson Group Ltd.
6.03%3.48M--+3.48M
Blue Owl Credit Private Fund Advisors LLC
3.39%1.96M--+1.96M
Eli Lilly and Company
1.91%1.10M--+1.10M
Carolyn BertozziFounder & Chair of Scientific Advisory Board
1.57%904.82K--+904.82K
Venrock Management, LLC
1.13%651.79K--+651.79K
Aetna TrombleyCEO, Secretary, President & Director
0.72%415.26K--+415.26K
Clare OzawaFormer Independent Director
0.36%205.16K--+205.16K
William RieflinIndependent Chair of the Board
0.16%89.78K--+89.78K
Steven StabenChief Scientific Officer
0.10%55.45K--+55.45K
Laurent FischerIndependent Director
0.06%33.27K--+33.27K
Chin Hyok LeeChief Medical Officer
0.00%0.00--+0
Jane Pritchett HendersonIndependent Director
0.00%0.00--+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy